Background

BCLS Acquisition Corp.

About us

We are a newly organized blank check company incorporated on August 26, 2020 as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

We intend to focus on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries. In particular, we will pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.

Our sponsor is an affiliate of Bain Capital Life Sciences, a leading life sciences investment manager with over $2.2 billion of assets under management as of June 30, 2020.

Our Team

SEC filings

A comprehensive list of SEC filings for BCLS Acquisition Corp. is available on the SEC website

Corporate Governance & Required Disclosures

Press Releases

BCLS Acquisition Corp. Announces Pricing of $125 Million Initial Public Offering

BCLS Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities, today announced the pricing of its initial public offering of 12,500,000...

Contact us

Please type your name.
Please type your name.
Please provide your email address.
Please tell us a little more.
Icon